Wolfgang Liedtke

Company: Anavex Life Sciences & Duke University

Job title: Head of Neurology, Professor of Neurology

Seminars:

Workshop B: Decoding Clinical Endpoints in ALS: Revolutionizing Drug Development with Emerging Biomarkers, ALS-FRS-R & Digital Endpoints 9:30 am

This workshop explores the ALS Functional Rating Scale-Revised (ALSFRS-R) as a cornerstone clinical endpoint, addressing its limitations and strategies to enhance its impact. We’ll investigate the role of digital biomarkers, such as wearables and smartphone-based assessments, alongside other primary and secondary endpoints like respiratory function, survival, and quality of life. Attendees will gain actionable insights…Read more

day: Pre Conference Day Workshop B